Catalyst Wire Dossier Catalyst Wire Dossier

RANKL-blockade

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for RANKL-blockade, covering 2024-09-25 to 2024-09-25. Get the full timeline:

Most recent: Clinical Trial Update: RANKL-blockade for the Treatment of Erosive Osteoarthritis (OA) of Interphalangeal Finger Joints [Phase 2]

See pricing